These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38324331)

  • 21. Phenotypes of non-attached Pseudomonas aeruginosa aggregates resemble surface attached biofilm.
    Alhede M; Kragh KN; Qvortrup K; Allesen-Holm M; van Gennip M; Christensen LD; Jensen PØ; Nielsen AK; Parsek M; Wozniak D; Molin S; Tolker-Nielsen T; Høiby N; Givskov M; Bjarnsholt T
    PLoS One; 2011; 6(11):e27943. PubMed ID: 22132176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diffusiophoretic Particle Penetration into Bacterial Biofilms.
    Somasundar A; Qin B; Shim S; Bassler BL; Stone HA
    ACS Appl Mater Interfaces; 2023 Jul; 15(28):33263-33272. PubMed ID: 37400078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Escherichia coli biofilm: development and therapeutic strategies.
    Sharma G; Sharma S; Sharma P; Chandola D; Dang S; Gupta S; Gabrani R
    J Appl Microbiol; 2016 Aug; 121(2):309-19. PubMed ID: 26811181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nanomaterials for Treating Bacterial Biofilms on Implantable Medical Devices.
    Tran HM; Tran H; Booth MA; Fox KE; Nguyen TH; Tran N; Tran PA
    Nanomaterials (Basel); 2020 Nov; 10(11):. PubMed ID: 33203046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanotechnologies for control of pathogenic microbial biofilms.
    Asare EO; Mun EA; Marsili E; Paunov VN
    J Mater Chem B; 2022 Jul; 10(27):5129-5153. PubMed ID: 35735175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biofilms: new ideas for an old problem.
    de Carvalho CC
    Recent Pat Biotechnol; 2012 Apr; 6(1):13-22. PubMed ID: 22420878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanically Robust Dissolving Microneedles Made of Supramolecular Photosensitizers for Effective Photodynamic Bacterial Biofilm Elimination.
    Wang H; Fu Y; Du S; Liu P; Ren J; Liu Y; Tao J; Zhang L; Zhu J
    ACS Appl Mater Interfaces; 2023 May; 15(21):25417-25426. PubMed ID: 37196354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The roles of extracellular DNA in the structural integrity of extracellular polymeric substance and bacterial biofilm development.
    Das T; Sehar S; Manefield M
    Environ Microbiol Rep; 2013 Dec; 5(6):778-86. PubMed ID: 24249286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of amylase and protease as antibiofilm agents by starch, casein, and yeast extract in Arthrobacter sp. CW01.
    Solihin J; Waturangi DE; Purwadaria T
    BMC Microbiol; 2021 Aug; 21(1):232. PubMed ID: 34425755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent Nanotechnologies to Overcome the Bacterial Biofilm Matrix Barriers.
    Lv X; Wang L; Mei A; Xu Y; Ruan X; Wang W; Shao J; Yang D; Dong X
    Small; 2023 Feb; 19(6):e2206220. PubMed ID: 36470671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemical Biology Strategies for Biofilm Control.
    Yang L; Givskov M
    Microbiol Spectr; 2015 Aug; 3(4):. PubMed ID: 26350311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ultrasound-Enhanced Antibacterial Activity of Polymeric Nanoparticles for Eradicating Bacterial Biofilms.
    Gopalakrishnan S; Gupta A; Makabenta JMV; Park J; Amante JJ; Chattopadhyay AN; Matuwana D; Kearney CJ; Rotello VM
    Adv Healthc Mater; 2022 Nov; 11(21):e2201060. PubMed ID: 36049222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advancing biofilm management through nanoformulation strategies: a review of dosage forms and administration routes.
    Simsekli O; Bilinmis I; Celik S; Arık G; Baba AY; Karakucuk A
    J Drug Target; 2023 Dec; 31(9):931-949. PubMed ID: 37831630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The biofilm matrix: multitasking in a shared space.
    Flemming HC; van Hullebusch ED; Neu TR; Nielsen PH; Seviour T; Stoodley P; Wingender J; Wuertz S
    Nat Rev Microbiol; 2023 Feb; 21(2):70-86. PubMed ID: 36127518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibiting bacterial cooperation is an evolutionarily robust anti-biofilm strategy.
    Dieltjens L; Appermans K; Lissens M; Lories B; Kim W; Van der Eycken EV; Foster KR; Steenackers HP
    Nat Commun; 2020 Jan; 11(1):107. PubMed ID: 31919364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of microbial biofilms - the contribution of micro and nanostructured materials.
    Grumezescu AM; Chifiriuc CM
    Curr Med Chem; 2014; 21(29):3311. PubMed ID: 24606506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent Advances in the Control of Clinically Important Biofilms.
    Krukiewicz K; Kazek-Kęsik A; Brzychczy-Włoch M; Łos MJ; Ateba CN; Mehrbod P; Ghavami S; Shyntum DY
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36076921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Engineered organic nanoparticles to combat biofilms.
    Sheng Y; Chen Z; Wu W; Lu Y
    Drug Discov Today; 2023 Feb; 28(2):103455. PubMed ID: 36403883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Abundance and Organization of
    Hahn MM; González JF; Hitt R; Tucker L; Gunn JS
    Infect Immun; 2021 Oct; 89(11):e0031021. PubMed ID: 34398679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bacterial biofilm infections, their resistance to antibiotics therapy and current treatment strategies.
    Singh A; Amod A; Pandey P; Bose P; Pingali MS; Shivalkar S; Varadwaj PK; Sahoo AK; Samanta SK
    Biomed Mater; 2022 Feb; 17(2):. PubMed ID: 35105823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.